Inhibrx (INBX) Earnings Date, Estimates & Call Transcripts $14.22 -0.50 (-3.40%) Closing price 03/25/2025 04:00 PM EasternExtended Trading$14.24 +0.01 (+0.11%) As of 08:30 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Inhibrx Latest Earnings SummaryLatest Q4 2024 Earnings DateMar. 17EstimatedActual EPS (Mar. 17) -$3.09 Missed By -$0.21 Consensus EPS (Mar. 17) -$2.88 Inhibrx issued Q4 2024 earnings on March 17, 2025, reporting an EPS of -$3.09, which missed the consensus estimate of -$2.88 by $0.21. Quarterly revenue was reported to be $0.10 million. With a trailing EPS of $0.00, Inhibrx's earnings are expected to decrease next year, from $104.88 to ($12.08) per share. Get Inhibrx Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Inhibrx and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataINBX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.INBX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Inhibrx Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:$104.88 EPSNext Year EPS Consensus Estimate: ($12.08) EPS Remove Ads Inhibrx Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails3/17/2025Q4 2024-$2.88-$3.09 -$0.21-$3.09-$0.10M8/13/2024Q2 2024-$3.60$125.48+$129.08$125.48-$0.10M2/28/2024Q4 2023-$1.07-$1.73 -$0.66-$1.73$0.10M$1.63M11/9/2023Q3 2023-$1.01-$1.10 -$0.09-$1.10-$0.12M8/7/2023Q2 2023-$1.02-$1.08 -$0.06-$1.08-$0.03M5/8/2023Q1 2023-$0.84-$1.12 -$0.28-$1.12$0.30M$0.02M Inhibrx Earnings - Frequently Asked Questions When did Inhibrx announce their last quarterly earnings? Inhibrx (NASDAQ:INBX) last announced its quarterly earning data on Monday, March 17, 2025. Learn more on INBX's earnings history. Did Inhibrx beat their earnings estimates last quarter? In the previous quarter, Inhibrx (NASDAQ:INBX) missed the analysts' consensus estimate of ($2.88) by $0.21 with a reported earnings per share (EPS) of ($3.09). Learn more on analysts' earnings estimate vs. INBX's actual earnings. How much revenue does Inhibrx generate each year? Inhibrx (NASDAQ:INBX) has a recorded annual revenue of $200,000.00. How much profit does Inhibrx generate each year? Inhibrx (NASDAQ:INBX) has a recorded net income of -$154.96 million. INBX has generated $0.00 earnings per share over the last four quarters. What is Inhibrx's EPS forecast for next year? Inhibrx's earnings are expected to decrease from $104.88 per share to ($12.08) per share in the next year. More Earnings Resources from MarketBeat Related Companies REPL Earnings Results COGT Earnings Results DAWN Earnings Results EOLS Earnings Results AVDL Earnings Results AVXL Earnings Results PHVS Earnings Results CDMO Earnings Results QURE Earnings Results ABCL Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio?Analysts Lift Archer Aviation Stock Despite Earnings Miss DigitalOcean Rides Cloud Wave and AI Hype to Strong EarningsPrice Targets on NVIDIA Rise in Front of Earnings Remove Ads This page (NASDAQ:INBX) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredHere’s Why Tesla Insiders are Dumping SharesTesla has been on a losing streak ever since Elon Musk first visited the White House in early 2025. Our res...Behind the Markets | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibrx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibrx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
